Jaakkola, Tiina

Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors. [electronic resource] - Basic & clinical pharmacology & toxicology Jul 2006 - 44-51 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1742-7835

10.1111/j.1742-7843.2006.pto_437.x doi


Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors
Cytochrome P-450 CYP2C8
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System--metabolism
Drug Interactions
Enzyme Inhibitors--pharmacology
Humans
Hypoglycemic Agents--pharmacokinetics
In Vitro Techniques
Microsomes, Liver--drug effects
NADP--metabolism
Pioglitazone
Thiazolidinediones--pharmacokinetics